NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Depreciation and Depletion of $15000.0 for Q4 2025, down 31.82% year-on-year from $22000.0 in Q4 2024, and down 11.76% on a QoQ basis from $17000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Depreciation and Depletion for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2025.
- Quarterly Depreciation and Depletion fell 31.82% year-over-year to $15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $74000.0 (down 93.73% YoY) and the FY2025 annual result came in at $68000.0, down 73.95% from the prior year.
- Depreciation and Depletion fell to $15000.0 in Q4 2025 per NBP's latest filing, from $17000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for NBP reached as high as $22000.0 in Q4 2024 and fell as low as $15000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | NovaBridge Biosciences | 397.57 Mn | 397.57 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Dec 31, 2020 | 755,220.95 |
| Dec 31, 2020 | 755,220.95 |
| Sep 30, 2020 | 382,291.49 |
| Sep 30, 2020 | 382,291.49 |
| Dec 31, 2019 | 425,074.79 |
| Dec 31, 2019 | 425,074.79 |